Honest, tested sleep product guides. Real prices, no paid rankings. Affiliate disclosure
Sleep News & Research

Daily Almonds and Sleep Quality: What the 2026 Trial Actually Found

A 2026 trial of 175 adults found daily almonds linked to better perceived sleep quality. What the study measured, what it did not prove, and the funding caveat.

Share
9 min read
By GetSome Rest editorial team · Independent sleep product guides Published · Last updated
A small ceramic bowl of raw almonds on a wooden nightstand beside a neatly made bed in a dim warm-lit bedroom

A randomised trial published in 2026 asked a refreshingly ordinary question: can a daily handful of almonds change how well you sleep? After 20 weeks, the 175 adults eating almonds said they slept better than the group eating a calorie-matched snack. The catch — and the reason this story is worth reading carefully — is that most of the trial's objective measures did not move. Here is what the researchers measured, what the results do and do not prove, and why the funding behind the study matters to how you read it.

Contents

At a Glance: What the Trial Found

Published in Frontiers in Nutrition in 2026 (Desai et al., article 1892442), the study is a randomised controlled trial — the strongest design nutrition research commonly gets — run among Indian adults with poor sleep quality. It is also a study with two different stories depending on which results you read: the self-reported ones, which improved, and the objective ones, which mostly did not.

  • The setup: 175 adults aged 21 to 55 with poor sleep quality, randomised to 60 grams of almonds daily or a calorie-matched control snack (khakra, chivda, crackers) for 20 weeks.
  • What improved: self-reported overall sleep quality, self-reported sleep efficiency, and self-reported time to fall asleep; melatonin levels were also higher in the almond group.
  • What did not: most objective sleep parameters showed no significant treatment effect, and wakefulness signals were inconsistent across the study population.
  • The funding: the trial was supported by the Almond Board of California, and the authors declared it in the paper.
  • The honest read: a promising signal for perceived sleep quality from a food-first habit — not proof that almonds fix sleep.

The trial's press coverage landed in September and October 2026, and the coverage split the same way the results do: industry releases led with the improvements, while independent analysts — notably Marion Nestle's Food Politics review — led with the gap between the subjective wins and the flat objective measures.

How to Read This Study Without Overreading It

Nutrition trials are easy to misread because the headline almost always outruns the data. Three questions keep this one honest.

First, subjective or objective? Self-reported sleep quality matters — feeling rested is a real outcome — but it is also the measure most sensitive to expectation. When people know they are eating a food widely believed to be healthy, some of the improvement can come from that belief rather than the food. Objective measures (actigraphy, lab values) are the check on that effect, and here they mostly did not confirm the subjective gains. That does not make the subjective results worthless; it makes them preliminary.

Second, who was studied? The participants were Indian adults aged 21 to 55 who already reported poor sleep quality, eating a diet in which the control snacks were khakra, chivda, and crackers. Results in that group do not automatically transfer to other ages, diets, or sleep situations, and a 20-week daily habit is a different intervention from an occasional snack.

Third, who paid? Industry funding is common in nutrition research, and it does not make a trial fraudulent. But the pattern here is the classic one independent reviewers watch for: a funder with a commercial interest, a press release that leads with the positive findings, and a conclusion that is more upbeat than the full results table. The safeguard is simple — read the results, not just the abstract's conclusion.

Raw almonds scattered on white linen bedding beside a glass of water on a bedside table in warm morning light
The trial dose was 60 grams of almonds a day — roughly 50 almonds — eaten daily for 20 weeks, not a one-off bedtime snack.

The Findings, Side by Side

Every headline result from the trial, what it actually measured, and the limit that applies to it.

FindingWhat was measuredReadingLimitation
Better self-reported sleep qualityParticipants' own ratings of overall sleep quality vs control snack groupAlmond group rated sleep better after 20 weeksSubjective measure; expectation effects possible
Higher sleep efficiencySelf-reported share of time in bed spent asleepAlmond group spent more of bed time asleepSelf-reported, not device-measured
Shorter time to fall asleepSelf-reported sleep onset latencyAlmond group reported falling asleep fasterSelf-reported; no objective confirmation highlighted
Less nighttime wakefulnessWakefulness during the nightEncouraging signals in some analysesNot consistently significant across the study population
Higher melatonin levelsBiochemical measurement in the almond groupLevels rose vs baselineOther biochemical and body-measurement outcomes showed no significant differences
Objective sleep parametersDevice and lab measures across the trialMost showed no significant treatment effectThe key reason this trial is a signal, not proof

The pattern is consistent: everything participants felt improved; almost everything measured objectively did not. That split is not unusual in nutrition research, and it is exactly why single trials should change grocery lists only modestly, if at all.

Our Verdict: The Honest Takeaway

Here is the most defensible reading of this research — what is supported, what is plausible, and what it simply does not show.

Supported: a daily almond habit was associated with better perceived sleep in this group. A randomised, controlled, 20-week trial is a serious design, and the subjective improvements were consistent across several measures — quality, efficiency, and time to fall asleep all moved the same direction. That is more than an anecdote.

Plausible but not proven: the nutrients explain it. Almonds contain magnesium, which supports normal nervous system and muscle function; tryptophan, which the body uses to make serotonin and melatonin; small amounts of melatonin itself; plus healthy unsaturated fats and antioxidants. That is a biologically sensible story. It is not, however, what the trial tested — it tested whole almonds, not magnesium or tryptophan, and the objective measures that would support a mechanism mostly stayed flat.

Not shown: that almonds treat poor sleep, or that they will work for you. One trial, one population, subjective endpoints, industry funding, and flat objective results add up to a reason to be interested, not a reason to prescribe yourself 50 almonds a day. If you like almonds, enjoy them. If you are struggling with sleep night after night, the evidence-based move is still a clinician, a consistent wind-down routine, and a dark, cool, quiet bedroom — the unglamorous trio no single food replaces.

What Independent Coverage Got Right

The trial's reception is a small case study in how the same paper produces two headlines. The Almond Board of California's release led with the improvements: better self-reported sleep quality, higher sleep efficiency, shorter time to fall asleep — all accurate as far as they go. Independent coverage, led by Marion Nestle's Food Politics review, read the same paper and landed somewhere cooler: eating almonds improved how people rated their sleep, but most objective sleep measures did not change, and the paper's conclusions put a positive spin on mixed results.

Both readings are honest about their slice of the data. The difference is which slice they treat as the story. The press release treats the subjective wins as the finding; the independent review treats the gap between subjective and objective results as the finding. For a reader deciding what to do, the second framing is the more useful one, because it tells you how much weight to put on the result.

There is also a calorie footnote the coverage mostly skipped: 60 grams of almonds is roughly 350 calories a day, every day, for five months. In a trial with calorie-matched control snacks, that balances out. In real life, adding 350 calories daily without removing something else is a dietary change with its own consequences, and it deserves a line in any honest summary.

The broader context helps too. This is not the first food-and-sleep trial to produce a subjective-objective split, and the pattern — people feel better, devices disagree — shows up across diet research. It is one reason sleep researchers keep returning to the same unglamorous fundamentals: regular timing, daylight, a wind-down routine, and a bedroom built for darkness and quiet.

How We Reported This Story

This article is a research roundup, so our method is literature coverage rather than product testing. We started from the trial's own record — Desai et al. 2026, Frontiers in Nutrition, DOI 10.3389/fnut.2026.1892442 — then cross-checked the design, sample, dose, duration, and headline findings against the Almond Board of California's release and independent coverage, including the Food Politics analysis. Where the release and the independent read disagreed, we reported both and said which one the full results support.

This story contains no product recommendations and no affiliate links — there is nothing here for us to earn a commission on, so there is nothing to disclose beyond that. We do not diagnose, prescribe, or treat: this is news about research, and persistent sleep problems deserve a clinician's input.

Frequently asked questions

What did the 2026 almond sleep trial actually find?

The trial randomised 175 Indian adults aged 21 to 55 who reported poor sleep quality into two groups for 20 weeks: one ate 60 grams of almonds a day, the other a calorie-matched control snack such as khakra, chivda, or crackers. The almond group reported better overall sleep quality, higher sleep efficiency (more of their time in bed spent asleep), and a shorter time to fall asleep. There were also encouraging signals toward less wakefulness during the night, though those were not consistently significant across the study population. The paper was published in Frontiers in Nutrition in 2026 (Desai et al.).

How many almonds did participants eat, and for how long?

Participants ate 60 grams of almonds daily — roughly 50 almonds — for 20 weeks, about five months. That is a substantial daily portion: around 350 calories of almonds every day, which matters if you are watching total intake. The trial tested a sustained daily habit, not an occasional bedtime snack, so its results say nothing about eating a handful once in a while.

Did the study prove that almonds improve sleep?

No — and the distinction is the whole story. The improvements were in subjective, self-reported measures: people said they slept better. Most objective parameters measured in the trial did not show significant treatment effects, and there were no significant differences for other biochemical or body-measurement outcomes. Melatonin levels were higher in the almond group, which the authors note, but the paper's own conclusion is carefully worded: almonds were associated with improvements in subjective sleep efficiency and sleep continuity. Association in one trial is not proof of cause, and it is certainly not evidence that almonds treat insomnia or any sleep disorder.

Who funded the study, and does it matter?

The trial was supported by the Almond Board of California, an industry body, and the authors declared that funding in the paper. Industry funding does not automatically invalidate research — the trial was randomised and controlled, which is a real strength — but independent commentators have flagged that the paper's conclusions put a positive spin on mixed results, emphasising the subjective wins while the objective measures stayed flat. When a study's funder sells the food being tested, read the results section before the press release.

Should I eat almonds before bed?

This trial does not answer that question, and it was not designed to. It tested almonds eaten daily as part of an overall diet, not timed as a bedtime snack, and it did not test whether almonds help any individual sleep better. If you already enjoy almonds, a daily portion is a reasonable, nutrient-dense food habit — they supply magnesium, tryptophan, healthy fats, and small amounts of melatonin — but 60 grams adds roughly 350 calories, and nut allergies are a hard stop. Persistent poor sleep deserves a conversation with a clinician, not a snack swap.

Key Takeaways

  • In a 20-week randomised trial of 175 Indian adults with poor sleep quality, 60 grams of almonds a day was linked to better self-reported sleep quality, higher sleep efficiency, and a shorter time to fall asleep.
  • The gains were subjective: most objective sleep measures did not change significantly, and nighttime wakefulness signals were inconsistent.
  • The trial was funded by the Almond Board of California — declared in the paper, and a real reason to weigh the results section over the press release.
  • The dose was substantial: roughly 50 almonds and 350 calories daily for five months, not an occasional bedtime snack.
  • Almonds are a sensible food habit if you enjoy them, but this trial is not evidence that they treat poor sleep — and it says nothing about eating almonds right before bed.

Reporting note: this article summarizes published research through October 2026. It is not medical advice, and it does not recommend any food or treatment.

Filed under: Sleep News & ResearchSources: Frontiers in Nutrition (Desai et al. 2026), Almond Board of California release, Food Politics analysis; research verified October 2026
Share this article

You might also like